Simcere Pharmaceutical Group SCR
-
Simcere Pharmaceutical ( SCR ): Q1 EPS of $0.08 in-line. Revenue of $77.4M (+5.2% Y/Y) misses by $7M. (PR)
Simcere Pharmaceutical ( SCR ): Q1 EPS of $0.08 in-line. Revenue of $77.4M (+5.2% Y/Y) misses by $7M . ( PR ) Post your comment!
-
Simcere Pharmaceutical ( SCR ): Q4 EPS of $0.12 beats by $0.07. Revenue of $81.2M (-9.2% Y/Y) misses by $6M. (PR)
Simcere Pharmaceutical ( SCR ): Q4 EPS of $0.12 beats by $0.07 . Revenue of $81.2M (-9.2% Y/Y) misses by $6M . ( PR ) Post your comment!
-
Why Merck May Stagnate In 2012
… China. It has been proactive in Chinese expansion by working with Simcere ( SCR ) on moving supply chains to needy areas. "The company and China's Simcere Pharmaceutical Group announced last week the establishment of a joint venture that will …
-
Revenues Rise at Simcere Pharmaceutical
Zacks.com submits: Simcere Pharmaceutical Group ’s ( SCR ) fourth quarter 2010 earnings ..... Quarterly Details Revenues at Simcere Pharma came in at $89.1 ..... products helped boost the margin. Simcere Pharma’s research Complete …
-
Dropping Coverage of Simcere
We are no longer providing equity research on Simcere Pharmaceutical SCR . We provide broad coverage of more than 1 , 800 companies , and adjust our coverage as necessary based on client demand and investor interest .
-
Simcere's Generics Unit Gets Boost
… our fair value estimate intact after Simcere Pharmaceutical's SCR announcement that 42 of its generic drugs ..... will provide additional tail winds for Simcere as more and more Chinese patients gain access to insurance coverage. Although Simcere is primarily focused on the development …
-
Weak Endu Sales Hurt Simcere's 1Q
Simcere Pharmaceutical's SCR first-quarter results marked another ..... expanded salesforce is mostly to blame for Simcere 's stunted profitability, and we ..... drug continue on a downward spiral. Simcere also announced its acquisition of a …
-
Antistroke Drugs Help Simcere's Growth
Simcere Pharmaceuticals SCR reported 17.1% year-over-year ..... improving nearly 1 percentage point, Simcere 's operating margin fell to 15.6 ..... to remain elevated going forward as Simcere continues to invest in its clinical …
-
Simcere Lowers Earnings Outlook
Simcere Pharmaceutical Group SCR recently released its updated revenue and earnings outlook for ..... inability to purchase state-run plans, are unable to afford Simcere 's pricier drugs. Although it appears fourth-quarter results …
-
Simcere Posts Steady 3Q
Simcere Pharmaceuticals SCR reported earnings today that were in ..... revenue growth. On the expense side, Simcere 's operating margin fell to 19.6 ..... margin contraction into our valuation as Simcere expands its research and development …